Mark Schoenberg - Net Worth and Insider Trading
Mark Schoenberg Net Worth
The estimated net worth of Mark Schoenberg is at least $2 Million dollars as of 2024-11-05. Mark Schoenberg is the Chief Medical Officer of UroGen Pharma Ltd and owns about 145,091 shares of UroGen Pharma Ltd (URGN) stock worth over $2 Million. Details can be seen in Mark Schoenberg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Schoenberg has not made any transactions after 2024-09-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Schoenberg
Mark Schoenberg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Schoenberg owns 1 companies in total, including UroGen Pharma Ltd (URGN) .
Click here to see the complete history of Mark Schoenberg’s form 4 insider trades.
Insider Ownership Summary of Mark Schoenberg
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| URGN | UroGen Pharma Ltd | 2024-09-09 | Chief Medical Officer |
Mark Schoenberg Latest Holdings Summary
Mark Schoenberg currently owns a total of 1 stock. Mark Schoenberg owns 145,091 shares of UroGen Pharma Ltd (URGN) as of September 9, 2024, with a value of $2 Million.
Latest Holdings of Mark Schoenberg
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| URGN | UroGen Pharma Ltd | 2024-09-09 | 145,091 | 12.11 | 1,756,327 |
Holding Weightings of Mark Schoenberg
Mark Schoenberg Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Schoenberg has made a total of 26 transactions in UroGen Pharma Ltd (URGN) over the past 5 years, including 2 buys and 24 sells. The most-recent trade in UroGen Pharma Ltd is the sale of 859 shares on September 9, 2024, which brought Mark Schoenberg around $11,236.
Insider Trading History of Mark Schoenberg
- 1
Mark Schoenberg Trading Performance
GuruFocus tracks the stock performance after each of Mark Schoenberg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Schoenberg is -16.97%. GuruFocus also compares Mark Schoenberg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Schoenberg within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark Schoenberg's insider trading performs compared to the benchmark.
Performance of Mark Schoenberg
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.2 | | | | | |
| Relative Return to S&P 500(%) | -0.7 | | | | | |
Mark Schoenberg Ownership Network
Ownership Network List of Mark Schoenberg
Ownership Network Relation of Mark Schoenberg
Mark Schoenberg Owned Company Details
What does UroGen Pharma Ltd do?
Who are the key executives at UroGen Pharma Ltd?
Mark Schoenberg is the Chief Medical Officer of UroGen Pharma Ltd. Other key executives at UroGen Pharma Ltd include General Counsel Jason Drew Smith , Chief Financial Officer Dong Kim , and Chief Financial Officer Molly Henderson .
UroGen Pharma Ltd (URGN) Insider Trades Summary
Over the past 18 months, Mark Schoenberg made 5 insider transaction in UroGen Pharma Ltd (URGN) with a net sale of 25,590. Other recent insider transactions involving UroGen Pharma Ltd (URGN) include a net sale of 15,307 shares made by Jason Drew Smith ,
In summary, during the past 3 months, insiders sold 2,380 shares of UroGen Pharma Ltd (URGN) in total and bought 0 shares, with a net sale of 2,380 shares. During the past 18 months, 40,897 shares of UroGen Pharma Ltd (URGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 40,897 shares.
UroGen Pharma Ltd (URGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
UroGen Pharma Ltd Insider Transactions
Mark Schoenberg Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Schoenberg. You might contact Mark Schoenberg via mailing address: C/o Urogen Pharma Ltd., 9 Ha Ta Asiya Street, Ra Anana L3 4365007.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
